AlloVir Inc. (ALVR) NASDAQ
$0.78 (0.01) (-1.05%)
Market Cap: $90.89M
As of 04/24/24 03:59 PM EDT. Market closed.
AlloVir Inc. (ALVR)
NASDAQ
$0.78
(0.01) (-1.05%)
Market Cap: $90.89M
As of 04/24/24 03:59 PM EDT. Market closed.
Add to Portfolio
allovir, inc., a clinical-stage cell therapy company, engages in the research and development of allogeneic, off-the-shelf multi-virus specific t cell (vst) therapies to prevent and treat devastating viral-associated diseases. the company's lead product is viralym-m, an allogeneic, off-the-shelf vst therapy, to treat bk virus, cytomegalovirus, adenovirus, epstein-barr virus, and human herpesvirus ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Scott M. McFarlane
Full Time Employees
131
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
CEO
Scott M. McFarlane
Full Time Employees
131
URL
Address
1100 Winter Street, MA, Waltham, 02451.
PRICE CHART FOR ALLOVIR INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$0.77
Previous Close
$0.79
Days Range
$0.76 - $0.82
52 week range
$0.62 - $6.12
Volume
147,469
Avg. Volume (30 days)
598,654
Market Cap
$90.89M
Dividend Yield
-
P/E
-
Shares Outstanding
114,915,661
Open
$0.77
Previous Close
$0.79
Days Range
$0.76 - $0.82
52 week range
$0.62 - $6.12
Volume
147,469
Avg. Volume (30 days)
598,654
Market Cap
$90.89M
Dividend Yield
-
P/E
-
Shares Outstanding
114,915,661
FINANCIAL STATEMENTS FOR ALLOVIR INC
LOADING...
INSIDER TRANSACTIONS FOR ALLOVIR INC
Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
Hagen Brett R | Chief Accounting Officer | Apr 22, 2024 | Sale | $0.75 | 480 | 360 | 77,619 | Apr 23, 2024, 04:15 PM |
Hagen Brett R | Chief Accounting Officer | Apr 19, 2024 | Sale | $0.75 | 473 | 355 | 78,099 | Apr 23, 2024, 04:15 PM |
Miller Edward | General Counsel | Apr 22, 2024 | Sale | $0.75 | 757 | 568 | 223,227 | Apr 23, 2024, 04:15 PM |
Miller Edward | General Counsel | Apr 19, 2024 | Sale | $0.75 | 626 | 470 | 223,984 | Apr 23, 2024, 04:15 PM |
Brainard Diana | Chief Executive Officer | Apr 19, 2024 | Sale | $0.75 | 9,601 | 7,207 | 802,935 | Apr 23, 2024, 04:15 PM |
Sinha Vikas | See Remarks | Apr 22, 2024 | Sale | $0.75 | 1,857 | 1,393 | 1,138,096 | Apr 23, 2024, 04:15 PM |
Sinha Vikas | See Remarks | Apr 19, 2024 | Sale | $0.75 | 1,521 | 1,142 | 1,139,953 | Apr 23, 2024, 04:15 PM |
Miller Edward | General Counsel | Apr 02, 2024 | Sale | $0.77 | 368 | 284 | 224,610 | Apr 04, 2024, 04:15 PM |
Brainard Diana | Chief Executive Officer | Apr 02, 2024 | Sale | $0.77 | 1,533 | 1,183 | 812,536 | Apr 04, 2024, 04:15 PM |
Hagen Brett R | Chief Accounting Officer | Apr 02, 2024 | Sale | $0.77 | 281 | 217 | 78,572 | Apr 04, 2024, 04:15 PM |
Sinha Vikas | See Remarks | Apr 02, 2024 | Sale | $0.77 | 885 | 683 | 1,141,474 | Apr 04, 2024, 04:15 PM |
Brainard Diana | Chief Executive Officer | Feb 21, 2024 | Sale | $0.71 | 5,155 | 3,650 | 814,069 | Feb 22, 2024, 04:18 PM |
Brainard Diana | Chief Executive Officer | Feb 20, 2024 | Sale | $0.70 | 3,097 | 2,153 | 819,224 | Feb 22, 2024, 04:18 PM |
Miller Edward | General Counsel | Feb 20, 2024 | Sale | $0.70 | 385 | 268 | 224,978 | Feb 22, 2024, 04:16 PM |
Sinha Vikas | See Remarks | Feb 20, 2024 | Sale | $0.70 | 2,893 | 2,011 | 1,142,359 | Feb 22, 2024, 04:15 PM |
Hagen Brett R | Chief Accounting Officer | Feb 20, 2024 | Sale | $0.70 | 494 | 343 | 78,853 | Feb 22, 2024, 04:15 PM |
Hagen Brett R | Chief Accounting Officer | Feb 08, 2024 | Sale | $0.67 | 11,150 | 7,494 | 79,347 | Feb 09, 2024, 08:01 PM |
Sinha Vikas | See Remarks | Feb 05, 2024 | Sale | $0.67 | 18,331 | 12,282 | 1,145,252 | Feb 06, 2024, 04:46 PM |
Miller Edward | General Counsel | Feb 05, 2024 | Sale | $0.67 | 8,869 | 5,942 | 225,363 | Feb 06, 2024, 04:40 PM |
Hagen Brett R | Chief Accounting Officer | Feb 05, 2024 | Sale | $0.67 | 5,792 | 3,881 | 90,497 | Feb 06, 2024, 04:39 PM |
Brainard Diana | Chief Executive Officer | Feb 05, 2024 | Sale | $0.67 | 41,421 | 27,752 | 822,321 | Feb 06, 2024, 04:38 PM |
Sinha Vikas | See Remarks | Jan 23, 2024 | Sale | $0.67 | 3,205 | 2,150 | 1,163,583 | Jan 25, 2024, 04:15 PM |
Brainard Diana | Chief Executive Officer | Jan 23, 2024 | Sale | $0.67 | 9,500 | 6,369 | 863,742 | Jan 25, 2024, 04:15 PM |
Hagen Brett R | Chief Accounting Officer | Jan 23, 2024 | Sale | $0.67 | 901 | 604 | 96,289 | Jan 25, 2024, 04:15 PM |
Miller Edward | General Counsel | Jan 23, 2024 | Sale | $0.67 | 1,302 | 873 | 234,232 | Jan 25, 2024, 04:15 PM |
Hagen Brett R | Chief Accounting Officer | Jan 04, 2024 | Sale | $0.64 | 310 | 198 | 97,190 | Jan 08, 2024, 04:15 PM |
Miller Edward | General Counsel | Jan 04, 2024 | Sale | $0.64 | 424 | 271 | 235,534 | Jan 08, 2024, 04:15 PM |
Sinha Vikas | See Remarks | Jan 04, 2024 | Sale | $0.64 | 961 | 614 | 1,166,788 | Jan 08, 2024, 04:15 PM |
Brainard Diana | Chief Executive Officer | Jan 04, 2024 | Sale | $0.64 | 1,664 | 1,063 | 873,242 | Jan 08, 2024, 04:15 PM |
Hagen Brett R | Chief Accounting Officer | Dec 27, 2023 | Sale | $0.74 | 28,335 | 20,838 | 97,500 | Jan 02, 2024, 07:36 PM |
Sinha Vikas | See Remarks | Nov 17, 2023 | Sale | $1.63 | 2,490 | 4,061 | 1,167,749 | Nov 21, 2023, 05:00 PM |
Brainard Diana | Chief Executive Officer | Nov 20, 2023 | Sale | $1.69 | 4,382 | 7,408 | 874,906 | Nov 21, 2023, 05:00 PM |
Brainard Diana | Chief Executive Officer | Nov 17, 2023 | Sale | $1.63 | 2,689 | 4,386 | 879,288 | Nov 21, 2023, 05:00 PM |
Hagen Brett R | Chief Accounting Officer | Nov 17, 2023 | Sale | $1.63 | 403 | 657 | 125,835 | Nov 21, 2023, 05:00 PM |
Hagen Brett R | Chief Accounting Officer | Oct 20, 2023 | Sale | $1.54 | 357 | 550 | 126,238 | Oct 23, 2023, 05:00 PM |
Hagen Brett R | Chief Accounting Officer | Oct 19, 2023 | Sale | $1.58 | 358 | 566 | 126,595 | Oct 23, 2023, 05:00 PM |
Brainard Diana | Chief Executive Officer | Oct 19, 2023 | Sale | $1.58 | 8,581 | 13,558 | 881,977 | Oct 23, 2023, 05:00 PM |
Sinha Vikas | See Remarks | Oct 20, 2023 | Sale | $1.54 | 1,475 | 2,273 | 1,170,239 | Oct 23, 2023, 05:00 PM |
Sinha Vikas | See Remarks | Oct 19, 2023 | Sale | $1.58 | 1,232 | 1,947 | 1,171,714 | Oct 23, 2023, 05:00 PM |
Brainard Diana | Chief Executive Officer | Oct 03, 2023 | Sale | $1.98 | 1,325 | 2,619 | 890,558 | Oct 05, 2023, 05:00 PM |
Sinha Vikas | See Remarks | Oct 03, 2023 | Sale | $1.98 | 755 | 1,492 | 1,172,946 | Oct 05, 2023, 05:00 PM |
Hagen Brett R | Chief Accounting Officer | Oct 03, 2023 | Sale | $1.98 | 222 | 439 | 126,953 | Oct 05, 2023, 05:00 PM |
Sinha Vikas | See Remarks | Aug 17, 2023 | Sale | $2.50 | 10,516 | 26,243 | 1,173,701 | Aug 21, 2023, 05:00 PM |
Brainard Diana | Chief Executive Officer | Aug 18, 2023 | Sale | $2.79 | 4,055 | 11,313 | 891,883 | Aug 21, 2023, 05:00 PM |
Brainard Diana | Chief Executive Officer | Aug 17, 2023 | Sale | $2.50 | 11,361 | 28,351 | 895,938 | Aug 21, 2023, 05:00 PM |
Hagen Brett R | Chief Accounting Officer | Aug 17, 2023 | Sale | $2.50 | 1,653 | 4,125 | 127,175 | Aug 21, 2023, 05:00 PM |
Brainard Diana | Chief Executive Officer | Jul 19, 2023 | Sale | $3.56 | 8,342 | 29,710 | 907,299 | Jul 21, 2023, 05:00 PM |
Hagen Brett R | Chief Accounting Officer | Jul 19, 2023 | Sale | $3.56 | 342 | 1,218 | 129,170 | Jul 21, 2023, 05:00 PM |
Hagen Brett R | Chief Accounting Officer | Jul 20, 2023 | Sale | $3.35 | 342 | 1,145 | 128,828 | Jul 21, 2023, 05:00 PM |
Sinha Vikas | See Remarks | Jul 20, 2023 | Sale | $3.35 | 1,437 | 4,810 | 1,184,217 | Jul 21, 2023, 05:00 PM |
Sinha Vikas | See Remarks | Jul 19, 2023 | Sale | $3.56 | 1,198 | 4,267 | 1,185,654 | Jul 21, 2023, 05:00 PM |
Brainard Diana | Chief Executive Officer | Jul 05, 2023 | Sale | $3.05 | 5,275 | 16,063 | 915,641 | Jul 06, 2023, 05:00 PM |
Sinha Vikas | See Remarks | Jul 05, 2023 | Sale | $3.05 | 2,983 | 9,084 | 1,186,852 | Jul 06, 2023, 05:00 PM |
GILEAD SCIENCES, INC. | 10% Owner | Jun 27, 2023 | Buy | $3.75 | 2,930,870 | 10,990,763 | 16,635,286 | Jun 28, 2023, 05:17 PM |
Hagen Brett R | Chief Accounting Officer | Jun 09, 2023 | Sale | $5.64 | 5,045 | 28,453 | 129,512 | Jun 13, 2023, 05:00 PM |
Brainard Diana | Chief Executive Officer | May 18, 2023 | Sale | $4.21 | 4,536 | 19,115 | 916,628 | May 19, 2023, 05:00 PM |
Sinha Vikas | See Remarks | Apr 20, 2023 | Sale | $3.63 | 1,466 | 5,315 | 1,185,055 | Apr 21, 2023, 04:05 PM |
Sinha Vikas | See Remarks | Apr 19, 2023 | Sale | $3.71 | 1,217 | 4,513 | 1,186,521 | Apr 21, 2023, 04:05 PM |
Hagen Brett R | Chief Accounting Officer | Apr 20, 2023 | Sale | $3.63 | 349 | 1,265 | 134,557 | Apr 21, 2023, 04:05 PM |
Hagen Brett R | Chief Accounting Officer | Apr 19, 2023 | Sale | $3.71 | 348 | 1,291 | 134,906 | Apr 21, 2023, 04:05 PM |
Brainard Diana | Chief Executive Officer | Apr 19, 2023 | Sale | $3.71 | 8,408 | 31,183 | 921,164 | Apr 21, 2023, 04:05 PM |
Brainard Diana | Chief Executive Officer | Feb 21, 2023 | Sale | $6.63 | 5,122 | 33,935 | 929,572 | Feb 23, 2023, 05:00 PM |
Sinha Vikas | See Remarks | Jan 20, 2023 | Sale | $5.14 | 1,426 | 7,335 | 1,030,238 | Jan 23, 2023, 07:00 PM |
Sinha Vikas | See Remarks | Jan 19, 2023 | Sale | $5.08 | 5,111 | 25,952 | 1,031,664 | Jan 23, 2023, 07:00 PM |
Miller Edward | General Counsel | Jan 20, 2023 | Sale | $5.14 | 541 | 2,783 | 148,458 | Jan 23, 2023, 07:00 PM |
Miller Edward | General Counsel | Jan 19, 2023 | Sale | $5.08 | 2,032 | 10,318 | 148,999 | Jan 23, 2023, 07:00 PM |
Hagen Brett R | Chief Accounting Officer | Jan 20, 2023 | Sale | $5.14 | 338 | 1,739 | 74,004 | Jan 23, 2023, 07:00 PM |
Hagen Brett R | Chief Accounting Officer | Jan 19, 2023 | Sale | $5.08 | 1,557 | 7,906 | 74,342 | Jan 23, 2023, 07:00 PM |
Brainard Diana | Chief Executive Officer | Jan 19, 2023 | Sale | $5.08 | 34,435 | 174,851 | 601,607 | Jan 23, 2023, 07:00 PM |
Brainard Diana | Chief Executive Officer | Nov 18, 2022 | Sale | $7.27 | 4,515 | 32,810 | 633,033 | Nov 21, 2022, 05:47 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Nov 16, 2022 | Sale | $7.50 | 16,074 | 120,528 | 333,726 | Nov 18, 2022, 04:05 PM |
Miller Edward | General Counsel | Nov 14, 2022 | Sale | $8.91 | 2,358 | 21,018 | 190,453 | Nov 16, 2022, 05:10 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Nov 11, 2022 | Sale | $8.20 | 36,592 | 299,904 | 349,800 | Nov 15, 2022, 04:53 PM |
Hagen Brett R | Chief Accounting Officer | Nov 10, 2022 | Sale | $8.00 | 5,989 | 47,925 | 93,910 | Nov 14, 2022, 05:06 PM |
Hagen Brett R | Chief Accounting Officer | Nov 11, 2022 | Sale | $8.18 | 18,011 | 147,258 | 75,899 | Nov 14, 2022, 05:06 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Nov 10, 2022 | Sale | $8.00 | 13,109 | 104,901 | 386,392 | Nov 10, 2022, 05:29 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Nov 08, 2022 | Sale | $8.00 | 299 | 2,392 | 399,501 | Nov 10, 2022, 05:29 PM |
Miller Edward | General Counsel | Oct 20, 2022 | Sale | $9.36 | 553 | 5,176 | 249,377 | Oct 26, 2022, 04:15 PM |
Atillasoy Ercem | See Remarks | Oct 21, 2022 | Sale | $8.48 | 1,527 | 12,956 | 131,372 | Oct 26, 2022, 04:15 PM |
Atillasoy Ercem | See Remarks | Oct 20, 2022 | Sale | $9.36 | 568 | 5,317 | 132,899 | Oct 26, 2022, 04:15 PM |
Hagen Brett R | Chief Accounting Officer | Oct 20, 2022 | Sale | $9.36 | 345 | 3,229 | 113,233 | Oct 26, 2022, 04:15 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Oct 20, 2022 | Sale | $9.36 | 1,070 | 10,016 | 399,800 | Oct 26, 2022, 04:15 PM |
Sinha Vikas | See Remarks | Oct 20, 2022 | Sale | $9.36 | 1,449 | 13,564 | 1,036,775 | Oct 26, 2022, 04:15 PM |
Sinha Vikas | See Remarks | Oct 19, 2022 | Sale | $9.36 | 1,449 | 13,564 | 1,036,775 | Oct 24, 2022, 06:28 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Oct 19, 2022 | Sale | $9.36 | 1,070 | 10,016 | 399,800 | Oct 24, 2022, 06:26 PM |
Hagen Brett R | Chief Accounting Officer | Oct 19, 2022 | Sale | $9.36 | 345 | 3,229 | 113,233 | Oct 24, 2022, 06:25 PM |
Hagen Brett R | Chief Accounting Officer | Oct 24, 2022 | Sale | $8.13 | 2,000 | 16,269 | 99,899 | Oct 24, 2022, 06:25 PM |
Hagen Brett R | Chief Accounting Officer | Oct 21, 2022 | Sale | $8.45 | 11,334 | 95,800 | 101,899 | Oct 24, 2022, 06:25 PM |
Miller Edward | General Counsel | Oct 19, 2022 | Sale | $9.36 | 553 | 5,176 | 249,377 | Oct 24, 2022, 06:24 PM |
Atillasoy Ercem | See Remarks | Oct 20, 2022 | Sale | $8.48 | 1,527 | 12,956 | 131,372 | Oct 24, 2022, 06:23 PM |
Atillasoy Ercem | See Remarks | Oct 19, 2022 | Sale | $9.36 | 568 | 5,317 | 132,899 | Oct 24, 2022, 06:23 PM |
Hallal David | Director | Oct 19, 2022 | Sale | $8.45 | 600,000 | 5,070,000 | 138,153 | Oct 21, 2022, 09:30 PM |
Hallal David | Director | Sep 29, 2022 | Sale | $7.35 | 400,000 | 2,940,920 | 720,965 | Sep 30, 2022, 04:05 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Sep 02, 2022 | Sale | $7.89 | 493 | 3,889 | 400,870 | Sep 06, 2022, 04:17 PM |
Brainard Diana | Chief Executive Officer | Aug 18, 2022 | Sale | $7.76 | 4,564 | 35,429 | 637,548 | Aug 19, 2022, 04:05 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Aug 16, 2022 | Sale | $8.30 | 15,590 | 129,473 | 386,363 | Aug 17, 2022, 05:58 PM |
Sinha Vikas | See Remarks | Jul 28, 2022 | Option Exercise | $4.61 | 3,253,796 | 15,000,000 | 16,674,766 | Aug 01, 2022, 04:38 PM |
Hallal David | Director | Jul 28, 2022 | Option Exercise | $4.61 | 3,253,796 | 15,000,000 | 16,674,766 | Aug 01, 2022, 04:38 PM |
Jovan-Embiricos Morana | Director | Jul 28, 2022 | Option Exercise | $4.61 | 1,626,898 | 7,500,000 | 2,038,583 | Aug 01, 2022, 04:35 PM |
Jovan-Embiricos Morana | Director | Jul 28, 2022 | Option Exercise | $4.61 | 325,379 | 1,499,997 | 668,072 | Aug 01, 2022, 04:35 PM |
Jovan-Embiricos Morana | Director | Jul 28, 2022 | Option Exercise | $4.61 | 684,622 | 3,156,108 | 2,059,884 | Aug 01, 2022, 04:35 PM |
Jovan-Embiricos Morana | Director | Jul 28, 2022 | Option Exercise | $4.61 | 3,253,796 | 15,000,000 | 16,674,766 | Aug 01, 2022, 04:35 PM |
Jovan-Embiricos Morana | Director | Jul 28, 2022 | Option Exercise | $4.61 | 867,678 | 3,999,996 | 867,678 | Aug 01, 2022, 04:35 PM |
Jovan-Embiricos Morana | Director | Jul 28, 2022 | Option Exercise | $4.61 | 1,393,874 | 6,425,759 | 4,193,874 | Aug 01, 2022, 04:35 PM |
ElevateBio, LLC | Director | Jul 28, 2022 | Option Exercise | $4.61 | 3,253,796 | 15,000,000 | 16,674,766 | Aug 01, 2022, 04:35 PM |
GADICKE ANSBERT | Director | Jul 28, 2022 | Option Exercise | $4.61 | 3,253,796 | 15,000,000 | 16,674,766 | Aug 01, 2022, 04:34 PM |
Atillasoy Ercem | See Remarks | Jul 21, 2022 | Sale | $5.38 | 1,533 | 8,245 | 133,467 | Jul 22, 2022, 04:22 PM |
Hallal David | Director | Jul 21, 2022 | Sale | $5.33 | 4,227 | 22,528 | 2,073,662 | Jul 21, 2022, 07:13 PM |
Sinha Vikas | See Remarks | Jul 20, 2022 | Sale | $5.21 | 1,432 | 7,467 | 938,224 | Jul 21, 2022, 07:12 PM |
Atillasoy Ercem | See Remarks | Jul 20, 2022 | Sale | $5.21 | 563 | 2,936 | 135,000 | Jul 21, 2022, 07:11 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Jul 20, 2022 | Sale | $5.21 | 1,058 | 5,517 | 401,953 | Jul 21, 2022, 07:11 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Jun 03, 2022 | Sale | $3.63 | 515 | 1,871 | 389,011 | Jul 06, 2022, 07:30 AM |
Hallal David | Director | Jun 03, 2022 | Sale | $3.67 | 65,725 | 241,106 | 2,077,889 | Jun 06, 2022, 04:05 PM |
Brainard Diana | Chief Executive Officer | May 18, 2022 | Sale | $4.33 | 29,135 | 126,257 | 492,165 | May 23, 2022, 04:44 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | May 17, 2022 | Sale | $4.40 | 15,262 | 67,167 | 389,526 | May 18, 2022, 08:57 AM |
Bornstein Jeffrey S | Director | Apr 26, 2022 | Buy | $4.64 | 5,000 | 23,196 | 40,197 | Apr 28, 2022, 07:46 AM |
Hallal David | Director | Apr 21, 2022 | Sale | $5.87 | 4,227 | 24,812 | 2,143,614 | Apr 22, 2022, 08:31 AM |
Sinha Vikas | See Remarks | Apr 20, 2022 | Sale | $6.68 | 1,162 | 7,767 | 906,633 | Apr 22, 2022, 08:29 AM |
VAN BEEK JEROEN B | Chief Commercial Officer | Apr 20, 2022 | Sale | $6.68 | 852 | 5,695 | 404,788 | Apr 22, 2022, 08:28 AM |
Atillasoy Ercem | See Remarks | Apr 20, 2022 | Sale | $6.68 | 453 | 3,028 | 123,150 | Apr 22, 2022, 08:23 AM |
Atillasoy Ercem | See Remarks | Apr 21, 2022 | Sale | $5.86 | 1,587 | 9,301 | 121,563 | Apr 22, 2022, 08:23 AM |
Hagen Brett R | Chief Accounting Officer | Apr 20, 2022 | Sale | $6.68 | 276 | 1,845 | 80,368 | Apr 22, 2022, 08:20 AM |
Hallal David | Director | Mar 11, 2022 | Sale | $7.37 | 25,244 | 186,068 | 2,147,841 | Mar 11, 2022, 07:14 PM |
Hallal David | Director | Mar 10, 2022 | Sale | $7.55 | 40,481 | 305,781 | 2,173,085 | Mar 11, 2022, 07:14 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Mar 02, 2022 | Sale | $9.01 | 516 | 4,651 | 382,384 | Mar 03, 2022, 04:15 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Feb 16, 2022 | Sale | $8.32 | 15,322 | 127,525 | 382,900 | Feb 18, 2022, 04:30 PM |
Bornstein Jeffrey S | Director | Feb 10, 2022 | Buy | $8.87 | 5,000 | 44,350 | 35,197 | Feb 10, 2022, 05:03 PM |
Atillasoy Ercem | See Remarks | Jan 25, 2022 | Sale | $8.24 | 4,639 | 38,248 | 100,347 | Jan 26, 2022, 04:15 PM |
Hallal David | Director | Jan 24, 2022 | Sale | $8.01 | 17,100 | 136,889 | 2,213,566 | Jan 25, 2022, 04:15 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Jan 20, 2022 | Sale | $8.75 | 4,656 | 40,752 | 398,222 | Jan 24, 2022, 04:15 PM |
Hagen Brett R | Chief Accounting Officer | Jan 20, 2022 | Sale | $8.75 | 1,563 | 13,680 | 63,202 | Jan 24, 2022, 04:15 PM |
Sinha Vikas | See Remarks | Jan 20, 2022 | Sale | $8.75 | 6,450 | 56,454 | 858,957 | Jan 24, 2022, 04:15 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Dec 02, 2021 | Sale | $17.06 | 514 | 8,770 | 402,878 | Dec 03, 2021, 04:14 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Nov 16, 2021 | Sale | $21.13 | 15,203 | 321,262 | 403,392 | Nov 18, 2021, 04:30 PM |
Leen Ann M. | Chief Scientific Officer | Nov 16, 2021 | Sale | $21.76 | 100 | 2,176 | 2,288,154 | Nov 16, 2021, 06:36 PM |
Leen Ann M. | Chief Scientific Officer | Nov 15, 2021 | Sale | $21.92 | 6,122 | 134,167 | 2,288,254 | Nov 16, 2021, 06:36 PM |
Leen Ann M. | Chief Scientific Officer | Nov 12, 2021 | Sale | $22.30 | 14,766 | 329,217 | 2,294,876 | Nov 16, 2021, 06:36 PM |
Jovan-Embiricos Morana | Director | Nov 10, 2021 | Sale | $24.76 | 120 | 2,972 | 342,693 | Nov 15, 2021, 05:17 PM |
Jovan-Embiricos Morana | Director | Nov 10, 2021 | Sale | $24.76 | 680 | 16,840 | 1,375,262 | Nov 15, 2021, 05:17 PM |
Jovan-Embiricos Morana | Director | Nov 09, 2021 | Sale | $24.79 | 572 | 14,179 | 342,813 | Nov 09, 2021, 06:43 PM |
Jovan-Embiricos Morana | Director | Nov 09, 2021 | Sale | $24.79 | 3,243 | 80,388 | 1,375,942 | Nov 09, 2021, 06:43 PM |
Jovan-Embiricos Morana | Director | Nov 05, 2021 | Sale | $24.80 | 1,257 | 31,180 | 343,385 | Nov 09, 2021, 06:43 PM |
Jovan-Embiricos Morana | Director | Nov 05, 2021 | Sale | $24.80 | 7,124 | 176,709 | 1,379,185 | Nov 09, 2021, 06:43 PM |
Jovan-Embiricos Morana | Director | Oct 27, 2021 | Sale | $24.78 | 330 | 8,177 | 344,642 | Oct 29, 2021, 05:02 PM |
Jovan-Embiricos Morana | Director | Oct 27, 2021 | Sale | $24.78 | 1,870 | 46,334 | 1,386,309 | Oct 29, 2021, 05:02 PM |
Jovan-Embiricos Morana | Director | Oct 25, 2021 | Sale | $24.82 | 1,165 | 28,913 | 344,972 | Oct 25, 2021, 06:24 PM |
Jovan-Embiricos Morana | Director | Oct 25, 2021 | Sale | $24.82 | 6,604 | 163,900 | 1,388,179 | Oct 25, 2021, 06:24 PM |
Jovan-Embiricos Morana | Director | Oct 22, 2021 | Sale | $24.77 | 859 | 21,277 | 346,137 | Oct 25, 2021, 06:24 PM |
Jovan-Embiricos Morana | Director | Oct 22, 2021 | Sale | $24.77 | 4,864 | 120,480 | 1,394,783 | Oct 25, 2021, 06:24 PM |
Jovan-Embiricos Morana | Director | Oct 21, 2021 | Sale | $24.75 | 15 | 371 | 346,996 | Oct 25, 2021, 06:24 PM |
Jovan-Embiricos Morana | Director | Oct 21, 2021 | Sale | $24.75 | 85 | 2,104 | 1,399,647 | Oct 25, 2021, 06:24 PM |
Atillasoy Ercem | See Remarks | Oct 21, 2021 | Sale | $24.23 | 1,514 | 36,690 | 104,986 | Oct 25, 2021, 04:12 PM |
Melian Agustin | Chief Medical Officer | Oct 04, 2021 | Sale | $23.91 | 18,689 | 446,862 | 461,540 | Oct 05, 2021, 09:05 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Oct 01, 2021 | Sale | $25.07 | 3,413 | 85,575 | 418,595 | Oct 01, 2021, 05:58 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Sep 30, 2021 | Sale | $25.17 | 12,171 | 306,294 | 422,008 | Oct 01, 2021, 05:58 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Sep 29, 2021 | Sale | $25.04 | 1,000 | 25,037 | 434,179 | Oct 01, 2021, 05:58 PM |
Melian Agustin | Chief Medical Officer | Sep 28, 2021 | Sale | $24.12 | 3,750 | 90,432 | 472,218 | Sep 29, 2021, 04:15 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Aug 17, 2021 | Sale | $17.82 | 15,205 | 270,953 | 441,608 | Sep 20, 2021, 06:33 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Jun 03, 2021 | Sale | $22.87 | 508 | 11,618 | 456,813 | Sep 20, 2021, 06:33 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | May 18, 2021 | Sale | $22.80 | 15,201 | 346,583 | 457,321 | Sep 20, 2021, 06:33 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Mar 02, 2021 | Sale | $37.93 | 512 | 19,420 | 472,522 | Sep 20, 2021, 06:33 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Feb 17, 2021 | Sale | $39.65 | 15,196 | 602,521 | 490,134 | Sep 20, 2021, 06:33 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Sep 17, 2021 | Sale | $25.08 | 5,916 | 148,362 | 435,179 | Sep 20, 2021, 06:33 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Sep 02, 2021 | Sale | $19.86 | 513 | 10,188 | 441,095 | Sep 20, 2021, 06:33 PM |
Melian Agustin | Chief Medical Officer | Sep 15, 2021 | Sale | $24.03 | 800 | 19,224 | 478,918 | Sep 20, 2021, 04:05 PM |
Melian Agustin | Chief Medical Officer | Jul 02, 2021 | Sale | $19.99 | 18,586 | 371,534 | 479,718 | Sep 20, 2021, 04:05 PM |
Melian Agustin | Chief Medical Officer | Apr 05, 2021 | Sale | $23.89 | 18,212 | 435,085 | 498,304 | Sep 20, 2021, 04:05 PM |
Melian Agustin | Chief Medical Officer | Sep 17, 2021 | Sale | $24.01 | 2,950 | 70,842 | 475,968 | Sep 20, 2021, 04:05 PM |
Melian Agustin | Chief Medical Officer | Mar 22, 2021 | Sale | $25.97 | 3,750 | 97,393 | 516,516 | Mar 24, 2021, 04:53 PM |
Leen Ann M. | Chief Scientific Officer | Mar 16, 2021 | Sale | $30.00 | 3,025 | 90,751 | 2,459,142 | Mar 18, 2021, 05:08 PM |
Wilson John Robert | Director | Mar 09, 2021 | Sale | $31.44 | 110,595 | 3,477,448 | 5,510,514 | Mar 11, 2021, 04:43 PM |
Wilson John Robert | Director | Mar 11, 2021 | Sale | $31.01 | 16,662 | 516,729 | 5,415,261 | Mar 11, 2021, 04:43 PM |
Wilson John Robert | Director | Mar 10, 2021 | Sale | $31.26 | 72,745 | 2,273,924 | 5,451,605 | Mar 11, 2021, 04:43 PM |
Brenner Malcolm | Director | Mar 05, 2021 | Sale | $31.10 | 48,091 | 1,495,500 | 843,094 | Mar 08, 2021, 04:12 PM |
Brenner Malcolm | Director | Mar 04, 2021 | Sale | $35.83 | 49,598 | 1,777,298 | 900,391 | Mar 08, 2021, 04:12 PM |
Vera Juan | Director | Mar 03, 2021 | Sale | $38.32 | 15,988 | 612,585 | 2,354,616 | Mar 03, 2021, 08:36 PM |
Vera Juan | Director | Mar 02, 2021 | Sale | $38.11 | 14,994 | 571,396 | 2,366,720 | Mar 03, 2021, 08:36 PM |
Vera Juan | Director | Mar 01, 2021 | Sale | $38.59 | 32,854 | 1,267,778 | 2,392,194 | Mar 03, 2021, 08:36 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Mar 01, 2021 | Sale | $38.78 | 5,932 | 230,034 | 489,830 | Mar 03, 2021, 08:36 PM |
Miller Edward | General Counsel | Mar 01, 2021 | Sale | $38.78 | 6,000 | 232,699 | 195,011 | Mar 03, 2021, 08:35 PM |
Leen Ann M. | Chief Scientific Officer | Mar 01, 2021 | Sale | $38.70 | 9,518 | 368,329 | 2,465,326 | Mar 03, 2021, 08:34 PM |
Brenner Malcolm | Director | Mar 03, 2021 | Sale | $37.95 | 17,915 | 679,950 | 930,884 | Mar 03, 2021, 08:34 PM |
Brenner Malcolm | Director | Mar 02, 2021 | Sale | $38.11 | 12,658 | 482,388 | 943,198 | Mar 03, 2021, 08:34 PM |
Brenner Malcolm | Director | Mar 01, 2021 | Sale | $38.64 | 21,694 | 838,227 | 955,794 | Mar 03, 2021, 08:34 PM |
Bornstein Jeffrey S | Director | Feb 18, 2021 | Sale | $40.43 | 20,583 | 832,119 | 812 | Feb 23, 2021, 07:57 PM |
Vera Juan | Director | Feb 23, 2021 | Sale | $39.40 | 8,850 | 348,684 | 2,411,489 | Feb 23, 2021, 07:44 PM |
Vera Juan | Director | Feb 22, 2021 | Sale | $42.57 | 14,321 | 609,614 | 2,424,044 | Feb 23, 2021, 07:44 PM |
Vera Juan | Director | Feb 19, 2021 | Sale | $41.79 | 13,233 | 553,011 | 2,426,935 | Feb 23, 2021, 07:44 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Feb 23, 2021 | Sale | $39.56 | 2,118 | 83,783 | 494,862 | Feb 23, 2021, 07:44 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Feb 22, 2021 | Sale | $42.54 | 2,800 | 119,118 | 498,480 | Feb 23, 2021, 07:44 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Feb 19, 2021 | Sale | $41.71 | 4,165 | 173,720 | 499,080 | Feb 23, 2021, 07:44 PM |
Leen Ann M. | Chief Scientific Officer | Feb 23, 2021 | Sale | $39.50 | 4,199 | 165,876 | 2,474,392 | Feb 23, 2021, 07:43 PM |
Leen Ann M. | Chief Scientific Officer | Feb 22, 2021 | Sale | $42.57 | 5,706 | 242,880 | 2,480,390 | Feb 23, 2021, 07:43 PM |
Leen Ann M. | Chief Scientific Officer | Feb 19, 2021 | Sale | $41.75 | 7,541 | 314,868 | 2,481,590 | Feb 23, 2021, 07:43 PM |
Hagen Brett R | Chief Accounting Officer | Feb 22, 2021 | Sale | $43.14 | 800 | 34,509 | 64,765 | Feb 23, 2021, 07:43 PM |
Brenner Malcolm | Director | Feb 19, 2021 | Sale | $41.78 | 11,990 | 500,935 | 988,531 | Feb 23, 2021, 07:42 PM |
Brenner Malcolm | Director | Feb 23, 2021 | Sale | $39.47 | 8,489 | 335,036 | 974,308 | Feb 23, 2021, 07:42 PM |
Brenner Malcolm | Director | Feb 22, 2021 | Sale | $42.57 | 11,423 | 486,246 | 986,197 | Feb 23, 2021, 07:42 PM |
Leen Ann M. | Chief Scientific Officer | Feb 18, 2021 | Sale | $40.81 | 2,700 | 110,194 | 2,491,531 | Feb 19, 2021, 08:44 AM |
Hagen Brett R | Chief Accounting Officer | Feb 18, 2021 | Sale | $40.11 | 741 | 29,724 | 66,106 | Feb 19, 2021, 08:44 AM |
VAN BEEK JEROEN B | Chief Commercial Officer | Feb 18, 2021 | Sale | $40.67 | 2,085 | 84,787 | 504,795 | Feb 19, 2021, 08:41 AM |
Vera Juan | Director | Feb 18, 2021 | Sale | $40.75 | 8,942 | 364,368 | 2,447,910 | Feb 19, 2021, 08:41 AM |
Brenner Malcolm | Director | Feb 18, 2021 | Sale | $40.75 | 6,757 | 275,366 | 1,006,303 | Feb 19, 2021, 08:38 AM |
Vera Juan | Director | Feb 16, 2021 | Sale | $41.86 | 10,400 | 435,365 | 2,457,536 | Feb 18, 2021, 09:25 PM |
Vera Juan | Director | Feb 17, 2021 | Sale | $40.34 | 7,460 | 300,930 | 2,454,570 | Feb 18, 2021, 09:25 PM |
Brenner Malcolm | Director | Feb 17, 2021 | Sale | $40.45 | 5,165 | 208,925 | 1,011,243 | Feb 18, 2021, 09:24 PM |
Brenner Malcolm | Director | Feb 16, 2021 | Sale | $41.85 | 6,220 | 260,332 | 1,013,543 | Feb 18, 2021, 09:24 PM |
Leen Ann M. | Chief Scientific Officer | Feb 17, 2021 | Sale | $40.45 | 2,286 | 92,468 | 2,493,617 | Feb 18, 2021, 09:22 PM |
Leen Ann M. | Chief Scientific Officer | Feb 16, 2021 | Sale | $41.88 | 3,050 | 127,733 | 2,494,317 | Feb 18, 2021, 09:22 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Feb 17, 2021 | Sale | $40.36 | 2,300 | 92,837 | 507,130 | Feb 18, 2021, 09:20 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Feb 16, 2021 | Sale | $41.86 | 3,100 | 129,770 | 508,030 | Feb 18, 2021, 09:20 PM |
Hagen Brett R | Chief Accounting Officer | Feb 16, 2021 | Sale | $41.91 | 3,050 | 127,816 | 68,926 | Feb 18, 2021, 09:18 PM |
Hagen Brett R | Chief Accounting Officer | Feb 17, 2021 | Sale | $40.42 | 2,320 | 93,763 | 68,026 | Feb 18, 2021, 09:18 PM |
VAN BEEK JEROEN B | Chief Commercial Officer | Feb 02, 2021 | Sale | $41.19 | 48,910 | 2,014,603 | 510,730 | Feb 04, 2021, 04:35 PM |
Melian Agustin | Chief Medical Officer | Feb 02, 2021 | Sale | $41.19 | 54,849 | 2,259,230 | 520,266 | Feb 04, 2021, 04:35 PM |
Jovan-Embiricos Morana | Director | Aug 03, 2020 | Buy | $17.00 | 2,900,000 | 49,300,000 | 2,800,000 | Aug 06, 2020, 06:06 AM |
VAN BEEK JEROEN B | Chief Commercial Officer | Aug 03, 2020 | Buy | $17.00 | 3,000 | 51,000 | 524,640 | Aug 05, 2020, 09:55 PM |
Brainard Diana | Director | Aug 03, 2020 | Buy | $17.00 | 6,300 | 107,100 | 6,300 | Aug 05, 2020, 09:42 PM |
Atillasoy Ercem | See Remarks | Aug 03, 2020 | Buy | $17.00 | 3,500 | 59,500 | 78,500 | Aug 05, 2020, 09:39 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Owner | Relationship | Date | Value($) |
Hagen Brett R | Chief Accounting Officer | 04/22/2024 | 360 |
Hagen Brett R | Chief Accounting Officer | 04/19/2024 | 355 |
Miller Edward | General Counsel | 04/22/2024 | 568 |
Miller Edward | General Counsel | 04/19/2024 | 470 |
Brainard Diana | Chief Executive Officer | 04/19/2024 | 7,207 |
Sinha Vikas | See Remarks | 04/22/2024 | 1,393 |
Sinha Vikas | See Remarks | 04/19/2024 | 1,142 |
Miller Edward | General Counsel | 04/02/2024 | 284 |
Brainard Diana | Chief Executive Officer | 04/02/2024 | 1,183 |
Hagen Brett R | Chief Accounting Officer | 04/02/2024 | 217 |
Sinha Vikas | See Remarks | 04/02/2024 | 683 |
Brainard Diana | Chief Executive Officer | 02/21/2024 | 3,650 |
Brainard Diana | Chief Executive Officer | 02/20/2024 | 2,153 |
Miller Edward | General Counsel | 02/20/2024 | 268 |
Sinha Vikas | See Remarks | 02/20/2024 | 2,011 |
Hagen Brett R | Chief Accounting Officer | 02/20/2024 | 343 |
Hagen Brett R | Chief Accounting Officer | 02/08/2024 | 7,494 |
Sinha Vikas | See Remarks | 02/05/2024 | 12,282 |
Miller Edward | General Counsel | 02/05/2024 | 5,942 |
Hagen Brett R | Chief Accounting Officer | 02/05/2024 | 3,881 |
Brainard Diana | Chief Executive Officer | 02/05/2024 | 27,752 |
Sinha Vikas | See Remarks | 01/23/2024 | 2,150 |
Brainard Diana | Chief Executive Officer | 01/23/2024 | 6,369 |
Hagen Brett R | Chief Accounting Officer | 01/23/2024 | 604 |
Miller Edward | General Counsel | 01/23/2024 | 873 |
Hagen Brett R | Chief Accounting Officer | 01/04/2024 | 198 |
Miller Edward | General Counsel | 01/04/2024 | 271 |
Sinha Vikas | See Remarks | 01/04/2024 | 614 |
Brainard Diana | Chief Executive Officer | 01/04/2024 | 1,063 |
Hagen Brett R | Chief Accounting Officer | 12/27/2023 | 20,838 |
Sinha Vikas | See Remarks | 11/17/2023 | 4,061 |
Brainard Diana | Chief Executive Officer | 11/20/2023 | 7,408 |
Brainard Diana | Chief Executive Officer | 11/17/2023 | 4,386 |
Hagen Brett R | Chief Accounting Officer | 11/17/2023 | 657 |
Hagen Brett R | Chief Accounting Officer | 10/20/2023 | 550 |
Hagen Brett R | Chief Accounting Officer | 10/19/2023 | 566 |
Brainard Diana | Chief Executive Officer | 10/19/2023 | 13,558 |
Sinha Vikas | See Remarks | 10/20/2023 | 2,273 |
Sinha Vikas | See Remarks | 10/19/2023 | 1,947 |
Brainard Diana | Chief Executive Officer | 10/03/2023 | 2,619 |
Sinha Vikas | See Remarks | 10/03/2023 | 1,492 |
Hagen Brett R | Chief Accounting Officer | 10/03/2023 | 439 |
Sinha Vikas | See Remarks | 08/17/2023 | 26,243 |
Brainard Diana | Chief Executive Officer | 08/18/2023 | 11,313 |
Brainard Diana | Chief Executive Officer | 08/17/2023 | 28,351 |
Hagen Brett R | Chief Accounting Officer | 08/17/2023 | 4,125 |
Brainard Diana | Chief Executive Officer | 07/19/2023 | 29,710 |
Hagen Brett R | Chief Accounting Officer | 07/19/2023 | 1,218 |
Hagen Brett R | Chief Accounting Officer | 07/20/2023 | 1,145 |
Sinha Vikas | See Remarks | 07/20/2023 | 4,810 |
Sinha Vikas | See Remarks | 07/19/2023 | 4,267 |
Brainard Diana | Chief Executive Officer | 07/05/2023 | 16,063 |
Sinha Vikas | See Remarks | 07/05/2023 | 9,084 |
GILEAD SCIENCES, INC. | 10% Owner | 06/27/2023 | 10,990,763 |
Hagen Brett R | Chief Accounting Officer | 06/09/2023 | 28,453 |
Brainard Diana | Chief Executive Officer | 05/18/2023 | 19,115 |
Sinha Vikas | See Remarks | 04/20/2023 | 5,315 |
Sinha Vikas | See Remarks | 04/19/2023 | 4,513 |
Hagen Brett R | Chief Accounting Officer | 04/20/2023 | 1,265 |
Hagen Brett R | Chief Accounting Officer | 04/19/2023 | 1,291 |
Brainard Diana | Chief Executive Officer | 04/19/2023 | 31,183 |
Brainard Diana | Chief Executive Officer | 02/21/2023 | 33,935 |
Sinha Vikas | See Remarks | 01/20/2023 | 7,335 |
Sinha Vikas | See Remarks | 01/19/2023 | 25,952 |
Miller Edward | General Counsel | 01/20/2023 | 2,783 |
Miller Edward | General Counsel | 01/19/2023 | 10,318 |
Hagen Brett R | Chief Accounting Officer | 01/20/2023 | 1,739 |
Hagen Brett R | Chief Accounting Officer | 01/19/2023 | 7,906 |
Brainard Diana | Chief Executive Officer | 01/19/2023 | 174,851 |
Brainard Diana | Chief Executive Officer | 11/18/2022 | 32,810 |
VAN BEEK JEROEN B | Chief Commercial Officer | 11/16/2022 | 120,528 |
Miller Edward | General Counsel | 11/14/2022 | 21,018 |
VAN BEEK JEROEN B | Chief Commercial Officer | 11/11/2022 | 299,904 |
Hagen Brett R | Chief Accounting Officer | 11/10/2022 | 47,925 |
Hagen Brett R | Chief Accounting Officer | 11/11/2022 | 147,258 |
VAN BEEK JEROEN B | Chief Commercial Officer | 11/10/2022 | 104,901 |
VAN BEEK JEROEN B | Chief Commercial Officer | 11/08/2022 | 2,392 |
Miller Edward | General Counsel | 10/20/2022 | 5,176 |
Atillasoy Ercem | See Remarks | 10/21/2022 | 12,956 |
Atillasoy Ercem | See Remarks | 10/20/2022 | 5,317 |
Hagen Brett R | Chief Accounting Officer | 10/20/2022 | 3,229 |
VAN BEEK JEROEN B | Chief Commercial Officer | 10/20/2022 | 10,016 |
Sinha Vikas | See Remarks | 10/20/2022 | 13,564 |
Sinha Vikas | See Remarks | 10/19/2022 | 13,564 |
VAN BEEK JEROEN B | Chief Commercial Officer | 10/19/2022 | 10,016 |
Hagen Brett R | Chief Accounting Officer | 10/19/2022 | 3,229 |
Hagen Brett R | Chief Accounting Officer | 10/24/2022 | 16,269 |
Hagen Brett R | Chief Accounting Officer | 10/21/2022 | 95,800 |
Miller Edward | General Counsel | 10/19/2022 | 5,176 |
Atillasoy Ercem | See Remarks | 10/20/2022 | 12,956 |
Atillasoy Ercem | See Remarks | 10/19/2022 | 5,317 |
Hallal David | Director | 10/19/2022 | 5,070,000 |
Hallal David | Director | 09/29/2022 | 2,940,920 |
VAN BEEK JEROEN B | Chief Commercial Officer | 09/02/2022 | 3,889 |
Brainard Diana | Chief Executive Officer | 08/18/2022 | 35,429 |
VAN BEEK JEROEN B | Chief Commercial Officer | 08/16/2022 | 129,473 |
Sinha Vikas | See Remarks | 07/28/2022 | 15,000,000 |
Hallal David | Director | 07/28/2022 | 15,000,000 |
Jovan-Embiricos Morana | Director | 07/28/2022 | 7,500,000 |
Jovan-Embiricos Morana | Director | 07/28/2022 | 1,499,997 |
Jovan-Embiricos Morana | Director | 07/28/2022 | 3,156,108 |
Jovan-Embiricos Morana | Director | 07/28/2022 | 15,000,000 |
Jovan-Embiricos Morana | Director | 07/28/2022 | 3,999,996 |
Jovan-Embiricos Morana | Director | 07/28/2022 | 6,425,759 |
ElevateBio, LLC | Director | 07/28/2022 | 15,000,000 |
GADICKE ANSBERT | Director | 07/28/2022 | 15,000,000 |
Atillasoy Ercem | See Remarks | 07/21/2022 | 8,245 |
Hallal David | Director | 07/21/2022 | 22,528 |
Sinha Vikas | See Remarks | 07/20/2022 | 7,467 |
Atillasoy Ercem | See Remarks | 07/20/2022 | 2,936 |
VAN BEEK JEROEN B | Chief Commercial Officer | 07/20/2022 | 5,517 |
VAN BEEK JEROEN B | Chief Commercial Officer | 06/03/2022 | 1,871 |
Hallal David | Director | 06/03/2022 | 241,106 |
Brainard Diana | Chief Executive Officer | 05/18/2022 | 126,257 |
VAN BEEK JEROEN B | Chief Commercial Officer | 05/17/2022 | 67,167 |
Bornstein Jeffrey S | Director | 04/26/2022 | 23,196 |
Hallal David | Director | 04/21/2022 | 24,812 |
Sinha Vikas | See Remarks | 04/20/2022 | 7,767 |
VAN BEEK JEROEN B | Chief Commercial Officer | 04/20/2022 | 5,695 |
Atillasoy Ercem | See Remarks | 04/20/2022 | 3,028 |
Atillasoy Ercem | See Remarks | 04/21/2022 | 9,301 |
Hagen Brett R | Chief Accounting Officer | 04/20/2022 | 1,845 |
Hallal David | Director | 03/11/2022 | 186,068 |
Hallal David | Director | 03/10/2022 | 305,781 |
VAN BEEK JEROEN B | Chief Commercial Officer | 03/02/2022 | 4,651 |
VAN BEEK JEROEN B | Chief Commercial Officer | 02/16/2022 | 127,525 |
Bornstein Jeffrey S | Director | 02/10/2022 | 44,350 |
Atillasoy Ercem | See Remarks | 01/25/2022 | 38,248 |
Hallal David | Director | 01/24/2022 | 136,889 |
VAN BEEK JEROEN B | Chief Commercial Officer | 01/20/2022 | 40,752 |
Hagen Brett R | Chief Accounting Officer | 01/20/2022 | 13,680 |
Sinha Vikas | See Remarks | 01/20/2022 | 56,454 |
VAN BEEK JEROEN B | Chief Commercial Officer | 12/02/2021 | 8,770 |
VAN BEEK JEROEN B | Chief Commercial Officer | 11/16/2021 | 321,262 |
Leen Ann M. | Chief Scientific Officer | 11/16/2021 | 2,176 |
Leen Ann M. | Chief Scientific Officer | 11/15/2021 | 134,167 |
Leen Ann M. | Chief Scientific Officer | 11/12/2021 | 329,217 |
Jovan-Embiricos Morana | Director | 11/10/2021 | 2,972 |
Jovan-Embiricos Morana | Director | 11/10/2021 | 16,840 |
Jovan-Embiricos Morana | Director | 11/09/2021 | 14,179 |
Jovan-Embiricos Morana | Director | 11/09/2021 | 80,388 |
Jovan-Embiricos Morana | Director | 11/05/2021 | 31,180 |
Jovan-Embiricos Morana | Director | 11/05/2021 | 176,709 |
Jovan-Embiricos Morana | Director | 10/27/2021 | 8,177 |
Jovan-Embiricos Morana | Director | 10/27/2021 | 46,334 |
Jovan-Embiricos Morana | Director | 10/25/2021 | 28,913 |
Jovan-Embiricos Morana | Director | 10/25/2021 | 163,900 |
Jovan-Embiricos Morana | Director | 10/22/2021 | 21,277 |
Jovan-Embiricos Morana | Director | 10/22/2021 | 120,480 |
Jovan-Embiricos Morana | Director | 10/21/2021 | 371 |
Jovan-Embiricos Morana | Director | 10/21/2021 | 2,104 |
Atillasoy Ercem | See Remarks | 10/21/2021 | 36,690 |
Melian Agustin | Chief Medical Officer | 10/04/2021 | 446,862 |
VAN BEEK JEROEN B | Chief Commercial Officer | 10/01/2021 | 85,575 |
VAN BEEK JEROEN B | Chief Commercial Officer | 09/30/2021 | 306,294 |
VAN BEEK JEROEN B | Chief Commercial Officer | 09/29/2021 | 25,037 |
Melian Agustin | Chief Medical Officer | 09/28/2021 | 90,432 |
VAN BEEK JEROEN B | Chief Commercial Officer | 08/17/2021 | 270,953 |
VAN BEEK JEROEN B | Chief Commercial Officer | 06/03/2021 | 11,618 |
VAN BEEK JEROEN B | Chief Commercial Officer | 05/18/2021 | 346,583 |
VAN BEEK JEROEN B | Chief Commercial Officer | 03/02/2021 | 19,420 |
VAN BEEK JEROEN B | Chief Commercial Officer | 02/17/2021 | 602,521 |
VAN BEEK JEROEN B | Chief Commercial Officer | 09/17/2021 | 148,362 |
VAN BEEK JEROEN B | Chief Commercial Officer | 09/02/2021 | 10,188 |
Melian Agustin | Chief Medical Officer | 09/15/2021 | 19,224 |
Melian Agustin | Chief Medical Officer | 07/02/2021 | 371,534 |
Melian Agustin | Chief Medical Officer | 04/05/2021 | 435,085 |
Melian Agustin | Chief Medical Officer | 09/17/2021 | 70,842 |
Melian Agustin | Chief Medical Officer | 03/22/2021 | 97,393 |
Leen Ann M. | Chief Scientific Officer | 03/16/2021 | 90,751 |
Wilson John Robert | Director | 03/09/2021 | 3,477,448 |
Wilson John Robert | Director | 03/11/2021 | 516,729 |
Wilson John Robert | Director | 03/10/2021 | 2,273,924 |
Brenner Malcolm | Director | 03/05/2021 | 1,495,500 |
Brenner Malcolm | Director | 03/04/2021 | 1,777,298 |
Vera Juan | Director | 03/03/2021 | 612,585 |
Vera Juan | Director | 03/02/2021 | 571,396 |
Vera Juan | Director | 03/01/2021 | 1,267,778 |
VAN BEEK JEROEN B | Chief Commercial Officer | 03/01/2021 | 230,034 |
Miller Edward | General Counsel | 03/01/2021 | 232,699 |
Leen Ann M. | Chief Scientific Officer | 03/01/2021 | 368,329 |
Brenner Malcolm | Director | 03/03/2021 | 679,950 |
Brenner Malcolm | Director | 03/02/2021 | 482,388 |
Brenner Malcolm | Director | 03/01/2021 | 838,227 |
Bornstein Jeffrey S | Director | 02/18/2021 | 832,119 |
Vera Juan | Director | 02/23/2021 | 348,684 |
Vera Juan | Director | 02/22/2021 | 609,614 |
Vera Juan | Director | 02/19/2021 | 553,011 |
VAN BEEK JEROEN B | Chief Commercial Officer | 02/23/2021 | 83,783 |
VAN BEEK JEROEN B | Chief Commercial Officer | 02/22/2021 | 119,118 |
VAN BEEK JEROEN B | Chief Commercial Officer | 02/19/2021 | 173,720 |
Leen Ann M. | Chief Scientific Officer | 02/23/2021 | 165,876 |
Leen Ann M. | Chief Scientific Officer | 02/22/2021 | 242,880 |
Leen Ann M. | Chief Scientific Officer | 02/19/2021 | 314,868 |
Hagen Brett R | Chief Accounting Officer | 02/22/2021 | 34,509 |
Brenner Malcolm | Director | 02/19/2021 | 500,935 |
Brenner Malcolm | Director | 02/23/2021 | 335,036 |
Brenner Malcolm | Director | 02/22/2021 | 486,246 |
Leen Ann M. | Chief Scientific Officer | 02/18/2021 | 110,194 |
Hagen Brett R | Chief Accounting Officer | 02/18/2021 | 29,724 |
VAN BEEK JEROEN B | Chief Commercial Officer | 02/18/2021 | 84,787 |
Vera Juan | Director | 02/18/2021 | 364,368 |
Brenner Malcolm | Director | 02/18/2021 | 275,366 |
Vera Juan | Director | 02/16/2021 | 435,365 |
Vera Juan | Director | 02/17/2021 | 300,930 |
Brenner Malcolm | Director | 02/17/2021 | 208,925 |
Brenner Malcolm | Director | 02/16/2021 | 260,332 |
Leen Ann M. | Chief Scientific Officer | 02/17/2021 | 92,468 |
Leen Ann M. | Chief Scientific Officer | 02/16/2021 | 127,733 |
VAN BEEK JEROEN B | Chief Commercial Officer | 02/17/2021 | 92,837 |
VAN BEEK JEROEN B | Chief Commercial Officer | 02/16/2021 | 129,770 |
Hagen Brett R | Chief Accounting Officer | 02/16/2021 | 127,816 |
Hagen Brett R | Chief Accounting Officer | 02/17/2021 | 93,763 |
VAN BEEK JEROEN B | Chief Commercial Officer | 02/02/2021 | 2,014,603 |
Melian Agustin | Chief Medical Officer | 02/02/2021 | 2,259,230 |
Jovan-Embiricos Morana | Director | 08/03/2020 | 49,300,000 |
VAN BEEK JEROEN B | Chief Commercial Officer | 08/03/2020 | 51,000 |
Brainard Diana | Director | 08/03/2020 | 107,100 |
Atillasoy Ercem | See Remarks | 08/03/2020 | 59,500 |
Load More Insider Transactions
FUNDS WITH A POSITION IN ALLOVIR INC
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
BLACKROCK INC. | 3,526,112 | 0.00006% | -8.31% | Other |
GEODE CAPITAL MANAGEMENT, LLC | 1,253,238 | 0.00009% | 6.27% | Other |
RENAISSANCE TECHNOLOGIES LLC | 761,965 | 0.0008% | 128.32% | Other |
D. E. SHAW & CO., INC. | 252,639 | 0.00015% | New | Other |
AQR CAPITAL MANAGEMENT LLC | 124,400 | 0.00016% | New | Other |
TUDOR INVESTMENT CORP ET AL | 49,620 | 0.00027% | No change | Event Driven, Other |
CHANGE IN SHARES OUTSTANDING FOR ALLOVIR INC
STOCK BUYBACKS FOR ALLOVIR INC
Period of Report
Previous Period
% Change in Shares
10-K/10-Q Filings
Quarter
Load More
Period of Report: 12/31/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
09/30/2023
0.25%
1Q
06/30/2023
20.66%
2Q
03/31/2023
22.37%
3Q
12/31/2022
48.95%
4Q
09/30/2022
34.41%
5Q
06/30/2022
77.11%
6Q
03/31/2022
78.42%
7Q
12/31/2021
80.20%
8Q
09/30/2021
81.34%
9Q
06/30/2021
83.14%
10Q
03/31/2021
83.59%
11Q
Load More
BUYBACK ANNOUNCEMENT(S) FOR ALLOVIR INC
LOADING...